Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  MMWR. Morbidity and mortality weekly report

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 20224542
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Clinical effectiveness and impact of 13-valent pneumococcal conjugate vaccines in preventing invasive pneumococcal disease among children with risk conditions: A systematic literature review

  2026cites this paper
• Evaluation of efficacy and effectiveness across the pneumococcal conjugate vaccine era

  2025cites this paper
• Endolysins: targeting Streptococcus pneumoniae in its major anatomical niches of infection and addressing the hurdles

  2025cites this paper
• Approaches to assess new pneumococcal vaccines for immunogenicity, development and licensure

  2025cites this paper
• The New Era of Pneumococcal Vaccination in Adults: What Is Next?

  2025cites this paper
• Effect of pneumococcal conjugate vaccine booster dose on prevention of invasive pneumococcal disease in British Columbia, 2003-2018.

  2025cites this paper
• Systematic review on serotypes distribution of pneumococcal pneumonia in adults and the elderly

  2025cites this paper
• Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease among children in the United States between 2010 and 2019: An indirect cohort study

  2024cites this paper
• Characterization of Streptococcus pneumoniae isolates obtained from the middle ear fluid of US children, 2011–2021

  2024cites this paper
• Immune Response to the 13-Valent Pneumococcal Conjugate Vaccine is Reduced in Infants Immunized during the Respiratory Viral Season.

  2024cites this paper
• Outpatient visits and antibiotic use due to higher valency pneumococcal vaccine serotypes.

  2024cites this paper
• Persistence of immunity in children aged 2 months and 7 months - 5 years old after primary immunization with 13-valent pneumococcal conjugate vaccine.

  2024cites this paper
• PCV15, a pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in infants and children

  2023cites this paper
• Pediatric outpatient visits and antibiotic use attributable to higher valency pneumococcal conjugate vaccine serotypes

  2023cites this paper
• Enhanced safety surveillance of STAMARIL® yellow fever vaccine provided under the expanded access investigational new drug program in the USA

  2023cites this paper
• Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries

  2023cites this paper
• Pneumococcal vaccination for adults

  2022cites this paper
• The metabolic hormone adiponectin affects the correlation between nutritional status and pneumococcal vaccine response in vulnerable indigenous children

  2022cites this paper
• Effectiveness of Pneumococcal Conjugate Vaccination Against Virus-Associated Lower Respiratory Tract Infection Among Adults: A Case-Control Study

  2022cites this paper
• Impact of 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease Among Adults With HIV—United States, 2008–2018

  2022cites this paper
• Streptococcus Pneumoniae-Associated Hemolytic Uremic Syndrome in the Era of Pneumococcal Vaccine

  2021cites this paper
• The Diagnosis and Management of Acute Otitis Media

  2021cites this paper
• Expanded Analysis of 20 Pneumococcal Serotypes Associated With Radiographically Confirmed Community-acquired Pneumonia in Hospitalized US Adults

  2021cites this paper
• Control of Streptococcal Infections: Is a Common Vaccine Target Achievable Against Streptococcus agalactiae and Streptococcus pneumoniae

  2021cites this paper
• Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance

  2021cites this paper
• Streptococcus pneumoniae, a pathogen of childhood pneumonia: an evaluation of isolated serotypes for vaccine effectiveness

  2021cites this paper
• Immunogenicity and safety of 7-valent pneumococcal conjugate vaccine (PCV7) in children aged 2-5 years in China.

  2021cites this paper
• Vaccination of immune-deficient patients

  2020cites this paper
• Immunization Adherence in Children With Sickle Cell Disease: A Single-Institution Experience.

  2020cites this paper
• INFECTION RISK, IMMUNIZATION RECOMMENDATIONS, AND ANTIMICROBIAL PROPHYLAXIS Preventing infections in children and adults with asplenia

  2020cites this paper
• Pneumococcal serotypes in children, clinical presentation and antimicrobial susceptibility in the PCV13 era

  2020cites this paper
• Multidisciplinary practice advancement: Role of a clinical pharmacy specialist in a pediatric specialty clinic.

  2020cites this paper
• Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease After Introduction Into Routine Pediatric Use

  2020cites this paper
• A Review of Current Vaccine Recommendations, Schedules for Children, Adults.

  2020cites this paper
• Results from the Survey of Antibiotic Resistance (SOAR) 2015-17 in Latin America (Argentina, Chile and Costa Rica): data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.

  2020cites this paper
• Nasopharyngeal Microbiota Profiles in Rural Venezuelan Children Are Associated With Respiratory and Gastrointestinal Infections

  2020cites this paper
• Recognition and Outcomes of Pneumococcal Meningitis in 2 Tertiary Pediatric Hospitals Since the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine

  2020cites this paper
• Preventing infections in children and adults with asplenia.

  2020cites this paper
• Recent Updates to the Advisory Committee On Immunization Practices Recommendations for Pneumococcal and Herpes Zoster Vaccination.

  2020cites this paper
• Pneumococcal Conjugate Vaccine Breakthrough Infections: 2001–2016

  2020cites this paper
• Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States

  2019cites this paper
• Changes in otitis media episodes and pressure equalization tube insertions among young children following introduction of the 13-valent pneumococcal conjugate vaccine: A birth-cohort based study.

  2019cites this paper
• Streptococcus pneumoniae colonization after introduction of 13-valent pneumococcal conjugate vaccine for US adults 65 years of age and older, 2015-2016.

  2019cites this paper
• Pneumococcal serotypes in children and relationship with clinical presentation and antimicrobial susceptibility in the PCV13 era

  2019cites this paper
• Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices

  2019cites this paper
• Why are people with asthma susceptible to pneumonia? A review of factors related to upper airway bacteria

  2019cites this paper
• Safety and Efficacy of Pneumococcal Vaccination in Pediatric Nephrotic Syndrome

  2019cites this paper
• Kawasaki disease and 13-valent pneumococcal conjugate vaccination among young children: A self-controlled risk interval and cohort study with null results

  2019cites this paper
• Functional antibodies as immunological endpoints to evaluate protective immunity against Shigella

  2019cites this paper
• Necroptotic Cell Death Promotes Adaptive Immunity Against Colonizing Pneumococci

  2019cites this paper
• Pneumococcal Polysaccharide Vaccination in Pediatric Inflammatory Bowel Disease

  2019cites this paper
• Infective Endocarditis in a Pediatric Patient.

  2019cites this paper
• Relationship between immune response to pneumococcal conjugate vaccines in infants and indirect protection after vaccine implementation

  2019cites this paper
• Cost-Utility Study of PCV13 Versus PPSV23 in Adults in Chile.

  2018cites this paper
• Impact of introduction of the 9-valent human papillomavirus vaccine on vaccination coverage of youth in North Carolina.

  2018cites this paper
• Vaccines to Prevent Pneumococcal Community-Acquired Pneumonia.

  2018cites this paper
• Re-emergence of pneumococcal colonization by vaccine serotype 19F in persons aged ≥5 years after 13-valent pneumococcal conjugate vaccine introduction-Alaska, 2008-2013.

  2018cites this paper
• Necrotizing Enterocolitis Cases Associated with Nosocomial Enterovirus Transmission in a Neonatal Unit.

  2018cites this paper
• Determinants of the receipt of the 9-valent human papillomavirus vaccine in the first year after introduction in North Carolina.

  2018cites this paper
• Factors Associated with Missed Opportunities for Simultaneous Administration of the Fourth Dose of Pneumococcal Conjugate Vaccine for Children in the United States.

  2018cites this paper
• Changes Over Time in Nasopharyngeal Colonization in Children Under 2 Years of Age at the Time of Diagnosis of Acute Otitis Media (1999–2014)

  2018cites this paper
• Trends in healthcare utilization and costs associated with pneumonia in the United States during 2008–2014

  2018cites this paper
• Recommendations and barriers to vaccination in systemic lupus erythematosus.

  2018cites this paper
• Pediatric acute mastoiditis in the era of pneumococcal vaccination

  2018cites this paper
• Pneumococcal and Meningococcal Vaccination among Michigan Children with Sickle Cell Disease

  2018cites this paper
• Immunization of Solid Organ Transplant Candidates and Recipients: A 2018 Update.

  2018cites this paper
• Cochlear implant provider awareness of vaccination guidelines

  2018cites this paper
• Blood Culture and Pleural Fluid Culture Yields in Pediatric Empyema Patients: A Retrospective Review, 1996–2016

  2018cites this paper
• Ambulatory Visits for Otitis Media before and after the Introduction of Pneumococcal Conjugate Vaccination

  2018cites this paper
• Observed Pneumococcal Carriage Among Alaska Native Children Who Received Reduced-Dose Schedules of 13-Valent Pneumococcal Conjugate Vaccine Between 2010 and 2012.

  2018cites this paper
• Effects of Pneumococcal Conjugate Vaccine on Genotypic Penicillin Resistance and Serotype Changes, Japan, 2010–2017

  2018cites this paper
• Reports of lower respiratory tract infection following dose 1 of RotaTeq and Rotarix vaccines to the Vaccine Adverse Event Reporting System (VAERS), 2008–2016

  2018cites this paper
• Effectiveness and practical uses of 23-valent pneumococcal polysaccharide vaccine in healthy and special populations

  2017cites this paper
• Development of an Extended-Specificity Multiplex Immunoassay for Detection of Streptococcus pneumoniae Serotype-Specific Antigen in Urine by Use of Human Monoclonal Antibodies

  2017cites this paper
• Colonization with 19F and other pneumococcal conjugate vaccine serotypes in children in St. Louis, Missouri, USA.

  2017cites this paper
• Etiology of acute otitis media and serotype distribution of Streptococcus pneumoniae and Haemophilus influenzae in Chilean children <5 years of age

  2017cites this paper
• Cost-effectiveness analysis of infant pneumococcal vaccination with PHiD-CV in Korea

  2017cites this paper
• Bronchiectasis in Children: Current Concepts in Immunology and Microbiology

  2017cites this paper
• A Population-Based Assessment of the Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines on Macrolide-Resistant Invasive Pneumococcal Disease: Emergence and Decline of Streptococcus pneumoniae Serotype 19A (CC320) With Dual Macrolide Resistance Mechanisms

  2017cites this paper
• Pediatric Acute Otitis Media in the Era of Pneumococcal Vaccination

  2017cites this paper
• Generalisability of vaccine effectiveness estimates: an analysis of cases included in a postlicensure evaluation of 13-valent pneumococcal conjugate vaccine in the USA

  2017cites this paper
• Bilan français des effets indésirables du vaccin Prévenar 13®

  2017cites this paper
• Serotype and MLST-based inference of population structure of clinical Streptococcus pneumoniae from invasive and noninvasive pneumococcal disease.

  2017cites this paper
• Trends in Diagnoses Among Hospitalizations of HIV-infected Children and Adolescents in the United States: 2003–2012

  2017cites this paper
• Fever Without Localizing Signs

  2017cites this paper
• Propensity of pneumococcal carriage serotypes to infect the lower airways of children with chronic endobronchial infections.

  2017cites this paper
• Impact of the Hajj on pneumococcal carriage and the effect of various pneumococcal vaccines.

  2017cites this paper
• Invasive pneumococcal infections in children following transplantation in the pneumococcal conjugate vaccine era

  2017cites this paper
• Pneumococcal vaccination in autoimmune rheumatic diseases

  2017cites this paper
• Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Clinical and Hypoxemic Childhood Pneumonia over Three Years in Central Malawi: An Observational Study

  2017cites this paper
• Development of an Extended-Specificity Multiplex Immunoassay for Detection of Streptococcus pneumoniae Serotype-Specific Antigen in Urine by Use of Human Monoclonal Antibodies

  2017cites this paper
• The Influence of Vaccine on Febrile Seizure

  2017cites this paper
• Vaccine-Preventable Diseases Requiring Hospitalization

  2017cites this paper
• Streptococcus pneumoniae and chronic endobronchial infections in childhood

  2017cites this paper
• Streptococcus pneumoniae serotype 19A: worldwide epidemiology

  2017cites this paper
• Implementing the Synchronized Global Switch from Trivalent to Bivalent Oral Polio Vaccines—Lessons Learned From the Global Perspective

  2017cites this paper
• Childhood Vaccine Acceptance and Refusal among Warao Amerindian Caregivers in Venezuela; A Qualitative Approach

  2017cites this paper
• Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine Compared With 7-valent Pneumococcal Conjugate Vaccine Among Healthy Infants in China

  2016cites this paper
• Bias with respect to socioeconomic status: A closer look at zip code matching in a pneumococcal vaccine effectiveness study

  2016cites this paper
• Immunogenicity and Safety of the 13-Valent Pneumococcal Conjugate Vaccine versus the 23-Valent Polysaccharide Vaccine in Unvaccinated HIV-Infected Adults: A Pilot, Prospective Controlled Study

  2016cites this paper